Pharma
Global Anti-malarial Drugs Market Opportunities and Forecast 2020-2027
  • DLR2861
  • 19 March, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Anti-malarial Drugs Market, By Drug Type (Aminoquinolines,Quinoline-methanol (4 quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides and sulfones, Others),By Route of Administration (Oral,Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and opportunities and forecast 2020-2027

Anti-malarial Drugs  Market Overview

Antimalarial medicine are used for the treatment and bar of malaria infection. This market has been growing in recent years because of the high prevalence of malaria, particularly in developing and underdeveloped countries. according to the “World protozoal infection Report 2018” by World Health Organization (WHO), there have been an estimated 219 million cases and nearly 435,000 malaria-related deaths in 2017. Hence, the high prevalence of protozoal infection is driving the expansion of this market.

The other factors include the rise in awareness initiatives by governments and research for brand new anti-malarial drugs and therapies that are serving to this market grow. However, side-effects of anti-malarial medicine and therefore the presence of counterfeit and substandard drugs are restraining the general growth of this market.

Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Drug Type, Route of Administration, Distribution Channel and Region
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered Mylan Labs ,Cipla ,GlaxoSmithKline,Novartis ,Roche ,Bayer AG,Lincoln Pharmaceuticals , Strides Pharma Science, Glenmark Pharmaceuticals,Alliance Pharmaceuticals.


The covid-19 Impact on Anti-malarial Drugs  Market:

Whereas, the chemicals and accouterments sectors were relatively affected during the pandemic. This is primarily due to uncut demand for chemicals for healthcare, life wisdom, and drawing agents. However, other elements of chemical and material sectors such as types of paints, industrial oil, construction materials are facing reduction in demand. Strict lockdown reflected in a nearly 50-60% reduction in force for raw supply and availability, which directly affected the manufacturing process. Further, halt on numerous end-use diligence directly affected the chemical demand each around the world.
 
Anti-malarial Drugs  Market Segment Overview



By  Drug type , aminoquinoline segment is predicted to witness significant growth within the anti-malaria drugs market over the forecast period, owing to the increasing number of product approvals and launches for this drug during this drug class.
 
By Route of Administration , Oral and  Injectable segment accounted market share throughout the forecast period.
 
By  Distribution Channel ,the retail pharmacy segment is calculable to remain highest throughout the forecast period.
 
Market Analysis, Insights and Forecast – By Drug Type
·       Aminoquinolines
·       Quinoline-methanol (4-quinolinemethanols)
·       Cinchona Alkaloids
·       Biguanides
·       Sulfonamides and sulfones
·       Others

Market Analysis, Insights and Forecast – By Route of Administration
·       Oral
·       Injectable
 
Market Analysis, Insights and Forecast – By Distribution Channel
·       Hospital Pharmacies
·       Retail Pharmacies
·       Online Pharmacies
 
Anti-malarial Drugs  Market Regional Overview

Region-wise, in terms of regions ,The Middle East and Africa are accounted for Africa market share and are expected to continue this trend, because of a rapid surge within the prevalence of malaria within the region. in step with the world Health Organization (WHO), there have been calculable 228 million cases of protozoal infection worldwide in 2018, out of that UN agency African Region carried a disproportionately high share of the worldwide malaria burden. thus the center East and Africa region are expected to possess one in every of the biggest shares within the total anti-malarial medicine market.
On the opposite aspect, Asia-Pacific is additionally calculable to register the quickest growth thanks to the rise in awareness concerning the employment of antiprotozoal medicine for early designation of the infection for higher treatment.

Anti-malarial Drugs -market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Anti-malarial Drugs  Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Anti-malarial Drugs  are highlighted below.

·       In 2019, Shin Poong Pharmaceutical Co.Ltd, South Korea, and Medicines for malaria Venture (MMV) launched Pyramax, associate anti-malarial drug combination of pyronardine and artesunate, in Uganada.

Anti-malarial Drugs  Market, Key Players -

·       Mylan Labs
·       Cipla
·       GlaxoSmithKline
·       Novartis
·       Roche
·       Bayer AG
·       Lincoln Pharmaceuticals
·       Strides Pharma Science
·       Glenmark Pharmaceuticals
·       Alliance Pharmaceuticals

Frequently Asked Questions (FAQ) :

Q1. What is the total CAGR expected to be recorded for the Anti-malarial Drugs market during the forecast period?

A. Anti-malarial Drugs market is expected to record a CAGR of ~ 4.7% during the forecast period.

Q2. Which segment is projected to hold the largest share in the Anti-malarial Drugs Market?

A. Retail Pharmacies segment is projected to hold the largest share in the Anti-malarial Drugs Market.

Q3. What are the driving factors for the Anti-malarial Drugs market?

A. The high prevalence of malaria in low and middle-income countries and massive growth of healthcare these are main factors driving the growth of automotive lighting market

Q4. Which Segments are covered in the Anti-malarial Drugs market report?

A. Drugs Type , Route of Administration,Distribution Channel and Region, these segments are covered in the Anti-malarial Drugs market report.

Q5. Which are the prominent players offering Fuel Dispenser?

A. Mylan Labs ,Cipla ,GlaxoSmithKline,Novartis ,Roche ,Bayer AG,Lincoln Pharmaceuticals , Strides Pharma Science, Glenmark Pharmaceuticals,Alliance Pharmaceuticals
Anti-malarial Drugs Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Anti-malarial Drugs Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Drug Type
        • 5.2.1. Aminoquinolines
        • 5.2.2. Quinoline-methanol (4-quinolinemethanols)
        • 5.2.3. Cinchona Alkaloids
        • 5.2.4. Biguanides
        • 5.2.5. Sulfonamides and sulfones
        • 5.2.6. Others
      • 5.3. Market Analysis, Insights and Forecast – By Route of Administration
        • 5.3.1. Oral
        • 5.3.2. Injectable
      • 5.4. Market Analysis, Insights and Forecast – By Distribution Channel
        • 5.4.1. Hospital Pharmacies
        • 5.4.2. Retail Pharmacies
        • 5.4.3. Online Pharmacies
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Europe
        • 5.5.3. Asia Pacific
        • 5.5.4. Latin America, Middle East, and Africa

      6. North America Anti-malarial Drugs Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Drug Type
        • 6.2.1. Aminoquinolines
        • 6.2.2. Quinoline-methanol (4-quinolinemethanols)
        • 6.2.3. Cinchona Alkaloids
        • 6.2.4. Biguanides
        • 6.2.5. Sulfonamides and sulfones
        • 6.2.6. Others
      • 6.3. Market Analysis, Insights and Forecast – By Route of Administration
        • 6.3.1. Oral
        • 6.3.2. Injectable
      • 6.4. Market Analysis, Insights and Forecast – By Distribution Channel
        • 6.4.1. Hospital Pharmacies
        • 6.4.2. Retail Pharmacies
        • 6.4.3. Online Pharmacies
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. UK
        • 6.5.2. Germany
        • 6.5.3. France
        • 6.5.4. Italy
        • 6.5.5. Spain
        • 6.5.6. Russia
        • 6.5.7. Rest of Europe

      7. Asia Pacific Anti-malarial Drugs Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Drug Type
        • 7.2.1. Aminoquinolines
        • 7.2.2. Quinoline-methanol (4-quinolinemethanols)
        • 7.2.3. Cinchona Alkaloids
        • 7.2.4. Biguanides
        • 7.2.5. Sulfonamides and sulfones
        • 7.2.6. Others
      • 7.3. Market Analysis, Insights and Forecast – By Route of Administration
        • 7.3.1. Oral
        • 7.3.2. Injectable
      • 7.4. Market Analysis, Insights and Forecast – By Distribution Channel
        • 7.4.1. Hospital Pharmacies
        • 7.4.2. Retail Pharmacies
        • 7.4.3. Online Pharmacies
      • 7.5. Market Analysis, Insights and Forecast – By Country
        • 7.5.1. China
        • 7.5.2. India
        • 7.5.3. Japan
        • 7.5.4. Australia
        • 7.5.5. South East Asia
        • 7.5.6. Rest of Asia Pacific

      8. Latin America, Middle East, and Africa Anti-malarial Drugs Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Drug Type
        • 8.2.1. Aminoquinolines
        • 8.2.2. Quinoline-methanol (4-quinolinemethanols)
        • 8.2.3. Cinchona Alkaloids
        • 8.2.4. Biguanides
        • 8.2.5. Sulfonamides and sulfones
        • 8.2.6. Others
      • 8.3. Market Analysis, Insights and Forecast – By Route of Administration
        • 8.3.1. Oral
        • 8.3.2. Injectable
      • 8.4. Market Analysis, Insights and Forecast – By Distribution Channel
        • 8.4.1. Hospital Pharmacies
        • 8.4.2. Retail Pharmacies
        • 8.4.3. Online Pharmacies
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. Brazil
        • 8.5.2. Saudi Arabia
        • 8.5.3. UAE
        • 8.5.4. Rest of LAMEA

      9. Competitive Analysis

      • 9.1. Company Market Share Analysis, 2018
      • 9.2. Key Industry Developments
      • 9.3. Company Profile
      • 9.4. Mylan Labs
        • 9.4.1. Business Overview
        • 9.4.2. Segment 1 & Service Offering
        • 9.4.3. Overall Revenue
        • 9.4.4. Geographic Presence
        • 9.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 9.5. •Cipla
      • 9.6. •GlaxoSmithKline
      • 9.7. •Novartis
      • 9.8. •Roche
      • 9.9. •Bayer AG
      • 9.10. •Lincoln Pharmaceuticals
      • 9.11. •Strides Pharma Science
      • 9.12. •Glenmark Pharmaceuticals

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      [email protected]

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934